Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Clinical trial NCT01803022 · COMPLETED
Trial details
- NCT number
- NCT01803022
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.